Citadel Advisors
AGN

Citadel Advisors’s Allergan plc AGN Stock Holding History

Citadel Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,402,442
Closed -$603M – 10921
2020
Q1 		$603M Buy
3,402,442
+2,269,606
+200% +$427M 0.27% 35
2019
Q4 		$217M Sell
1,132,836
-1,007,121
-47% -$182M 0.09% 157
2019
Q3 		$360M Buy
2,139,957
+337,582
+19% +$55M 0.17% 65
2019
Q2 		$302M Buy
1,802,375
+1,522,634
+544% +$211M 0.14% 88
2019
Q1 		$41M Buy
279,741
+193,208
+223% +$28M 0.02% 806
2018
Q4 		$11.6M Sell
86,533
-954,337
-92% -$156M 0.01% 1735
2018
Q3 		$198M Buy
1,040,870
+483,428
+87% +$88.8M 0.09% 171
2018
Q2 		$92.9M Sell
557,442
-36,804
-6% -$5.91M 0.05% 403
2018
Q1 		$100M Buy
594,246
+4,267
+0.7% +$716K 0.05% 324
2017
Q4 		$96.5M Buy
589,979
+442,009
+299% +$79.3M 0.06% 341
2017
Q3 		$30.3M Buy
147,970
+106,198
+254% +$24.7M 0.02% 824
2017
Q2 		$10.2M Buy
41,772
+34,085
+443% +$8.01M 0.01% 1448
2017
Q1 		$1.84M Sell
7,687
-888,689
-99% -$207M ﹤0.01% 3164
2016
Q4 		$188M Buy
896,376
+867,236
+2,976% +$180M 0.19% 69
2016
Q3 		$6.71M Sell
29,140
-344,216
-92% -$84.1M 0.01% 1709
2016
Q2 		$86.3M Buy
373,356
+335,910
+897% +$77.4M 0.1% 171
2016
Q1 		$10M Buy
37,446
+28,500
+319% +$8.16M 0.01% 1194
2015
Q4 		$2.8M Sell
8,946
-483,008
-98% -$144M ﹤0.01% 2403
2015
Q3 		$134M Buy
491,954
+188,393
+62% +$57.9M 0.13% 143
2015
Q2 		$92.1M Sell
303,561
-318,612
-51% -$95M 0.08% 262
2015
Q1 		$185M Sell
622,173
-40,784
-6% -$11.6M 0.18% 86
2014
Q4 		$171M Sell
662,957
-904,116
-58% -$226M 0.17% 90
2014
Q3 		$378M Buy
1,567,073
+548,368
+54% +$123M 0.4% 19
2014
Q2 		$227M Sell
1,018,705
-64,988
-6% -$13.5M 0.26% 47
2014
Q1 		$223M Buy
1,083,693
+565,300
+109% +$112M 0.26% 36
2013
Q4 		$87.1M Sell
518,393
-58,583
-10% -$9.16M 0.11% 185
2013
Q3 		$83.1M Buy
576,976
+242,147
+72% +$32.3M 0.13% 157
2013
Q2 		$42.3M Buy
+334,829
New +$37.9M 0.07% 306

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Citadel Advisors's AGN Position: Q2 2020 in Review

Citadel Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,402,442 shares — an estimated $603M sold.

Citadel Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $603M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Citadel Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Citadel Advisors sold 3,402,442 Allergan plc shares in Q2 2020, an estimated $603M.
  • Citadel Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Citadel Advisors's Allergan plc position peaked at $603M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.